References
1. London GM, Safar ME, Pannier B. Aortic aging in ESRD: structural,
hemodynamic, and mortality implications. Journal of the American Society
of Nephrology. 2016;27(6):1837–46.
2. Moody WE, Edwards NC, Chue CD, Ferro CJ, Townend JN. Arterial disease
in chronic kidney disease. Heart. 2013;99(6):365–72.
3. Vlachopoulos C, Xaplanteris P, Aboyans V, Brodmann M, Cífková R,
Cosentino F, et al. The role of vascular biomarkers for primary and
secondary prevention. A position paper from the European Society of
Cardiology Working Group on peripheral circulation: Endorsed by the
Association for Research into Arterial Structure and Physiology (ARTERY)
Society. Atherosclerosis. 2015;241(2):507–32.
4. Briet M, Boutouyrie P, Laurent S, London GM. Arterial stiffness and
pulse pressure in CKD and ESRD. Kidney international.
2012;82(4):388–400.
5. Ferreira JP, Girerd N, Pannier B, Rossignol P, London GM. High
pulse-wave velocity defines a very high cardiovascular risk cohort of
dialysis patients under age 60. American Journal of Nephrology.
2017;45(1):72–81.
6. Gunes Y, Tuncer M, Yildirim M, Guntekin U, Gumrukcuoglu HA, Sahin M.
A novel echocardiographic method for the prediction of coronary artery
disease. Medical Science Monitor. 2008;14(9):MT42–6.
7. Nagy E, Jermendy AL, Merkely B, Maurovich-Horvat P. Clinical
importance of epicardial adipose tissue. Archives of medical science:
AMS. 2017;13(4):864.
8. Patel VB, Shah S, Verma S, Oudit GY. Epicardial adipose tissue as a
metabolic transducer: role in heart failure and coronary artery disease.
Heart failure reviews. 2017;22(6):889–902.
9. Guzzardi MA, Iozzo P. Fatty heart, cardiac damage, and inflammation.
The review of diabetic studies: RDS. 2011;8(3):403.
10. Karatas A, Canakci E, Bektas O, Bayrak T, Bayrak A, Altınbas A, et
al. Relationship of epicardial fat tissue thickness with oxidant
biomarkers in chronic kidney disease. Bratislavske lekarske listy.
2018;119(9):566.
11. Nakanishi K, Fukuda S, Tanaka A, Otsuka K, Taguchi H, Yoshikawa J,
et al. Epicardial adipose tissue accumulation is associated with renal
dysfunction and coronary plaque morphology on multidetector computed
tomography. Circulation Journal. 2015;CJ-15.
12. Cordeiro AC, Amparo FC, Oliveira MA, Amodeo C, Smanio P, Pinto IM,
et al. Epicardial fat accumulation, cardiometabolic profile and
cardiovascular events in patients with stages 3–5 chronic kidney
disease. Journal of Internal Medicine. 2015;278(1):77–87.
13. McCullough PA, Chinnaiyan KM, Agrawal V, Danielewicz E, Abela GS.
Amplification of atherosclerotic calcification and Mönckeberg’s
sclerosis: a spectrum of the same disease process. Advances in chronic
kidney disease. 2008;15(4):396–412.
14. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson Jr
SK. Carotid-artery intima and media thickness as a risk factor for
myocardial infarction and stroke in older adults. New England Journal of
Medicine. 1999;340(1):14–22.
15. Briet M, Bozec E, Laurent S, Fassot C, London G, Jacquot C, et al.
Arterial stiffness and enlargement in mild-to-moderate chronic kidney
disease. Kidney international. 2006;69(2):350–7.
16. Roumeliotis A, Roumeliotis S, Panagoutsos S, Theodoridis M, Argyriou
C, Tavridou A, et al. Carotid intima-media thickness is an independent
predictor of all-cause mortality and cardiovascular morbidity in
patients with diabetes mellitus type 2 and chronic kidney disease. Renal
Failure. 2019;41(1):131–8.
17. Zuo J, Hu Y, Chang G, Chu S, Tan I, Butlin M, et al. Relationship
between arterial stiffness and chronic kidney disease in patients with
primary hypertension. Journal of human hypertension. 2020;34(8):577–85.
18. Ma Y-C, Zuo L, Chen J-H, Luo Q, Yu X-Q, Li Y, et al. Modified
glomerular filtration rate estimating equation for Chinese patients with
chronic kidney disease. Journal of the American Society of Nephrology.
2006;17(10):2937–44.
19. Sen T, Tufekcioglu O, Ozdemir M, Tuncez A, Uygur B, Golbasi Z, et
al. A new echocardiographic parameter of aortic stiffness and
atherosclerosis in patients with coronary artery disease: aortic
propagation velocity. Journal of cardiology. 2013;62(4):236–40.
20. Edwards NC, Ferro CJ, Townend JN, Steeds RP. Aortic distensibility
and arterial–ventricular coupling in early chronic kidney disease: a
pattern resembling heart failure with preserved ejection fraction.
Heart. 2008;94(8):1038–43.
21. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et
al. Aortic stiffness is an independent predictor of all-cause and
cardiovascular mortality in hypertensive patients. Hypertension.
2001;37(5):1236–41.
22. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM.
Impact of aortic stiffness attenuation on survival of patients in
end-stage renal failure. Circulation. 2001;103(7):987–92.
23. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D,
Stehman-Breen C, et al. Cardiovascular mortality risk in chronic kidney
disease: comparison of traditional and novel risk factors. Jama.
2005;293(14):1737–45.
24. Aydın E, Altın C, Sakallıoğlu O, Yılmaz M, Gezmiş E, Sade LE, et al.
Epicardial adipose tissue thickness and carotid intima-media thickness
in hemodialysis patients. Acta Cardiologica Sinica. 2017;33(3):266.
25. Ozturk MT, Ebinç FA, Okyay GU, Kutlugün AA. Epicardial adiposity is
associated with microalbuminuria in patients with essential
hypertension. Acta Cardiologica Sinica. 2017;33(1):74.
26. Akbas EM, Demirtas L, Ozcicek A, Timuroglu A, Bakirci EM, Hamur H,
et al. Association of epicardial adipose tissue,
neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with
diabetic nephropathy. International journal of clinical and experimental
medicine. 2014;7(7):1794.
27. Song G, Qiao W, Liu K, Yu X. Epicardial adipose tissue in patients
with chronic kidney disease: a meta-analysis study and trial sequential
analysis. International Urology and Nephrology. 2020;1–11.
28. Sheng Y, Zhao D, Ma Q, Gao Y. Association between epicardial fat
volume and coronary artery calcification in patients with chronic kidney
disease. Zhonghua xin xue Guan Bing za zhi. 2017;45(2):121–5.
29. Ozkurt S, Karavelioğlu Y, Musmul A. Echocardiographic evaluation of
epicardial adipose tissue in non-diabetic, non-hypertensive hemodialysis
patients. Renal failure. 2013;35(6):891–5.
30. Turan MN, Gungor O, Asci G, Kircelli F, Acar T, Yaprak M, et al.
Epicardial adipose tissue volume and cardiovascular disease in
hemodialysis patients. Atherosclerosis. 2013;226(1):129–33.
31. Patel ML, Sachan R, Singh GP, Chaudhary S, Gupta K, Atam V, et al.
Assessment of subclinical atherosclerosis and endothelial dysfunction in
chronic kidney disease by measurement of carotid intima media thickness
and flow-mediated vasodilatation in North Indian population. Journal of
family medicine and primary care. 2019;8(4):1447.
32. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of
ultrasonographic measurement of carotid intima media thickness in
dialysis patients. Journal of the American Society of Nephrology.
2001;12(11):2458–64.
33. Turan Y, Turan E. Aortic Stiffness Index And Carotid Intima-Media
Thickness Are Independently Associated With The Presence Of
Microalbuminuria In Patients With Type 2 Diabetes Mellitus. Diabetes,
Metabolic Syndrome and Obesity: Targets and Therapy. 2019;12:1889.
34. Margekar V, Thakur S, Jatav O, Tiwari D, Gupta M, Yadav P. Carotid
Intimal Medial Thickness (CIMT) in Patients of Chronic Kidney Disease
(CKD) and its Association with CKD Staging. Journal of Contemporary
Medical Research. 2020;7(3):C7–9.